Here are Siltanen’s comments regarding Orion’s recent press release.
Orion announced on Tuesday that it has agreed on a change to the license agreement with Alligator Bioscience. The license between the companies, which previously included a royalty obligation, will be converted into a perpetual, fully paid-up, and royalty-free license for Orion. The one-time payment for the agreement is 3.5 MEUR, which is small on the scale of the group.